Generics Cos. Haven't Shaken Label Claims Post-Mensing
Following the landmark Mensing and Bartlett rulings, the biggest threat to a generic-drug maker may be allegations that it failed to update a warning label to match the brand-name version, which...To view the full article, register now.
Already a subscriber? Click here to view full article